Focus Areas
OPHTHALMOLOGICAL
DRY EYE DIAGNOSTICS
AXIM is currently preparing a 510(k) submission to seek FDA clearance to commercialize its updated Lactoferrin diagnostic device and intends to submit a subsequent 510(k) application for its updated IgE diagnostic test.
These products are under development and have not yet received clearance from the U.S. Food and Drug Administration.
TEST DEVELOPMENT
INNOVATIVE DIAGNOSTIC SOLUTIONS
AXIM works with clients around the world on development of diagnostic solutions of all kinds for a variety of conditions and indications. For more information, please contact AXIM.